Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease—characterization and treatment compliance assessment

INTRODUCTION: Recent studies have reported a high prevalence of obstructive sleep apnoea (OSA) among patients with diffuse parenchymal lung disease (DPLD), mainly idiopathic pulmonary fibrosis (IPF). Effective OSA treatment appears to have a positive impact on morbidity and mortality in these patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Ana Verónica, Pereira, Nuno, Neves, Inês, Santos, Vanessa, Jesus, José Miguel, Melo, Natália, Mota, Patrícia Caetano, Morais, António, Drummond, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Canadian Society of Respiratory Therapists 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422053/
https://www.ncbi.nlm.nih.gov/pubmed/30996642
http://dx.doi.org/10.29390/cjrt-2018-005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422053/
https://www.ncbi.nlm.nih.gov/pubmed/30996642
http://dx.doi.org/10.29390/cjrt-2018-005

Ejemplares similares